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The purpose of this human study was to investigate the eﬀect of oxygen pretreatment in living kidney donors on early renal
function of transplanted kidney. Sixty living kidney donor individuals were assigned to receive either 8–10L/min oxygen (Group
I) by a non-rebreather mask with reservoir bag intermittently for one hour at four times (20, 16, 12, and 1 hours before
transplantation) or air (Group II). After kidney transplantation, urine output, blood urea nitrogen (BUN), serum creatinine,
need to additional diuretics (NTADs) in the ﬁrst 24hours after transplantation, delayed graft function (DGF), the creatinine
clearance (CrCL) on 10th day, and duration of hospital stay from the ﬁrst posttransplant day till normalization of renal function
was recorded and compared in two groups. Mean CrCL in posttransplant day 10, NTAD after 24 hours of transplantation,
and urine output during 6 hours after operation were signiﬁcantly better in Group I compared with Group II (P<. 05).
Also, DGF during the ﬁrst week after operation and duration of hospital stay was less in Group I compared with Group II.
Intermittent exposure of human living kidney donor to hyperoxic environment may improve renal function following kidney
transplantation.
1.Introduction
Preservation of renal function is an essential purpose
in renal transplantation and in many other vascular and
urological procedures where renal functional impairment
follows ischemia-reperfusion (I-R) injury [1]. Ischemic
injury occurs when the blood supply to a tissue is inter-
rupted, but paradoxically more severe tissue injury arises
when blood ﬂow is restored on reperfusion [2]. Renal
warm I-R injury happens during kidney transplantation and
h a sam a j o ri m p a c to nm o r b i d i t y[ 3], on cost increase [4],
and on prognosis [5, 6].
Delayed graft function (DGF) was deﬁned as hemodial-
ysis requirement during the ﬁrst week after renal transplan-
tation. Reperfusion injury is a risk factor for development of
DGF after transplantation [7].
Therefore, protective maneuvers before transplantation
could obviously proﬁt the fate of the organ. Murry et al.
[8] in 1986 demonstrated that the application of short-
time episodes of ischemia and reperfusion to the dog’s
myocardium led to the development of tolerance to subse-
quent more prolonged ischemia and reperfusion and imple-
ment the term “ischemic preconditioning” (IPC) to express
thisendogenousinducibleprotection.This phenomenonhas2 Journal of Transplantation
been primarily investigated and characterized in the heart
[9, 10], but it has also been explained in the liver [11], the
small intestine [12], lung [13], brain [14], and kidney [15].
Inducing brief episodes of ischemia and reperfusion in
human appears fairly aggressive and not satisfactory by
many surgeons [16]. Accordingly ﬁnding safer methods of
preconditioning against IR injury is crucial.
Amongst the most practical methods for induction of
ischemic tolerance in tissues is short-period exposure to
hyperoxia which has no signiﬁcant adverse eﬀects and
occasionally appears to be beneﬁcial (e.g., by maximizing
arterial oxygen saturation). In animal models, the protective
eﬀects of oxygen pretreatment on subsequent ischemia-
reperfusion injury have been conﬁrmed in heart [17, 18],
brain [19], spinal cord [20], and ﬁnally kidney [21, 22].
Wahhabaghai and colleagues [22] showed that repeated
exposure to hyperoxic(≥95% O2)e n vi r o n m e n tc a nd e c r e a s e
rat’s renal ischemia-reperfusion damage.
Sincefreeradicalformation isthemain causeofIRinjury
[1], the mechanism of hyperoxia-induced preconditioning
against IR injury appears to be induction of endogenous
defense strategies against free radicals by low grade oxidative
stress resulting from short period of exposure to hyperoxia
[18].
To the best of our knowledge, there is no human study
which indicates this eﬀect of oxygen pretreatment on renal
function oftransplanted kidney.Therefore, thepresent study
was undertaken to determine whether brief exposure to the
hyperoxia in living donors could improve renal function
measured throughout 10days after kidney transplantation.
2.MaterialandMethods
From October2007 to December2009, sixty ASA(American
society of Anesthesiology) III patients with end-stage renal
disease who had undergone ﬁrst kidney transplant from
a living donor, aged 18–65years old, with no history of
previous transplantation, human immunodeﬁciency, and
hepatitisBandCvirusinfectionwererecruitedtoparticipate
in this randomized, double blind clinical trial study.
The kidney donors were 18–55years old healthy (ASA
I) individuals who were evaluated for kidney donation by
corresponding nephrologists and their own recipients were
WBC cross match negative.
The study protocol was approved by the medical ethics
research committee of our university, and written informed
consent was obtained from each kidney donor.
Recipients with new onset of any major complications
(myocardial infarction, stroke, hemorrhagic shock, etc.)
after transplantation, female donors to male recipients, and
donors who were noncompliant with study protocol and
received maintenance anesthesia other than isoﬂurane were
excluded from the study.
At enrolment, living kidney donors were assigned by a
computer-generatedlistofrandomnumbers toreceiveeither
8–10L/minoxygen(Group I)by a non-rebreathermask with
r e s e r v o i rb a gi n t e r m i t t e n t l yf o ro n eh o u ra tf o u rt i m e s( 2 0 ,
16, 12, and 1 hours before transplantation) or air (Group II).
In the ﬁrst ﬁve donors in each group, an arterial blood
gas (ABG) test was done with permission of the participants
formeasuring theoxygenarterial partial pressure(PaO2)and
assessing the eﬀectiveness of oxygen administration.
Recipients and their medical team were blinded to
the study group assignments. Before transplant operation,
all recipients received 500mg IV methylprednisolone, 6–
8mg/kg cyclosporine A, and 1gram mycophenolate mofetil.
Data concerned recipients (age, weight, gender, primary
renal disease, timeondialysis, urinary outputstatus(oliguric
or anuric), type of dialysis, serology to hepatitis C and
B virus, and last panel-reactive antibodies), and donors
(age, gender, and serology to hepatitis C and B virus) were
recorded in both groups.
No anesthetic premedication was given to the recipients
and donors. Peripheral oxygen saturation (SpO2), electro-
cardiogram, noninvasive arterial blood pressure, and heart
rate were recorded in the operating room. After 3–5minutes
preoxygenation with 100% oxygen, anesthesia was induced
with thiopental 5mg/kg and fentanyl 3μg/kg followed
by atracurium 0.6mg/kg to facilitate tracheal intubation.
Anaesthesia was maintained with isoﬂurane 1–1.2% and
nitrous oxide 50% in oxygen, and patients were maintained
under controlled ventilation to achieve end-tidal CO2 values
of 32–35mmHg.
In recipients, fentanyl 1μg/kg was given as rescue med-
ication when insuﬃcient analgesia was noted (deﬁned as a
heart rate or systolic arterial blood pressure that exceeded
baseline valuesby 20%).Allrecipientsreceivednormal saline
0.9% 70mL/kg and furosemide 3mg/kg before completion
of vascular anastomosis. Residual neuromuscular blockade
was reversed by neostigmine 40μg/kg and atropine 20μg/ kg
at the end of surgery.
After emergence from anaesthesia, patients were cared
in the postanaesthetic care unit (PACU). They received
supplementalO2 atarateof2–4L/minwithnasalprongsand
were transferred to the kidney transplant intensive care unit
after stabilization.
In donors, induction and maintenance of anesthesia
were similar and so for recipient patients. In donors,
patients received 30mL/kg Ringer until just before open
nephrectomy. Afternephrectomy, thekidneywaspreparedin
University of Wisconsin (UW) solution at 4◦Ct e m p e r a t u r e
and immediately transplanted to recipients.
After kidney transplantation, urine output was moni-
tored closely for volume hourly for the ﬁrst 24hours and
recorded for statistical analysis during 1, 6, and 24 hours. If
the patients had urine output volume less than 200mL per
hour in spite of adequate ﬂuid therapy, additional diuretics
(furosemide 10mg per hour) were administered. Also, blood
urea nitrogen (BUN) and serum creatinine (sCr), serum
sodium and potassium were tested and recorded daily for
10days.
Urine sodium and creatinine were measured, and the
fractional excretion of sodium (FENa) was calculated on the
days 2 and 4 after kidney transplant. Any patients’ DGF was
recorded.
The creatinine clearance (CrCL) on 10thday and dura-
tion of hospital stay were also recorded in two groups.Journal of Transplantation 3
Duration of hospital stay was deﬁned as days required
for renal functions become stabilized after transplantation
day. Acute rejection (AR) was deﬁned based on clinical
and/orparaclinicaldata(biopsyorrenalarterycolorDoppler
sonography or nuclear scan of transplanted kidney). If any
patient had AR, it was recorded and treated according to the
standardprotocols.Maintenanceofimmunosuppressionwas
cyclosporine A 3-4mg/kg q12h and adjusted to maintain
trough blood level 150–300ng/mL, mycophenolate mofetil
500–1000mg q12h, and prednisolone 1mg/kg.
All data were analyzed with SPSS 16 (SPSS Inc, Chicago,
IL, USA). Patient characteristics were described as means ±
SDs for continuous variables and frequency for categorical
variables. Student’s t-test for unpaired data, or chi-square
analysis, was used as appropriate, to assess diﬀerences
between two groups. A P v a l u eo fl e s st h a n. 0 5w a sc o n s i d -
ered statistically signiﬁcant.
3.Results
Sixty patients completed the study criteria for randomiza-
tion.Sevenpatientsdroppedoutofthestudy(seeCONSORT
Statement, Figure 1).
There were no signiﬁcant diﬀerences between the two
study groups with respect to the data concerning recipients
(age, gender, duration of CRF, duration of hemodialysis,
the incidence of anuria-oliguria, and causes of chronic renal
failure) and donors(age and gender) (Table 1).Mean (± SD)
partial pressure of oxygen in arterial blood (PaO2)i nt h eﬁ r s t
ﬁve donor participants from group I and group II was 303 ±
7.8 and 85 ± 3.7mmHg, respectively.
Need to additional diuretic in the ﬁrst 24hours after
the operation was signiﬁcantly less in Group I compared to
Group II (P<. 05) (Table 2).
Urine output during 6hours after operation was signif-
icantly more in Group I compared to Group II (P<. 05)
(Table 2). The incidence of DGF was more in Group II (four
patients, i.e., 14.3%) compared to Group I (only one patient
i.e., 4%), but this diﬀerence was not signiﬁcant statistically
(Table 2).
There was no signiﬁcant diﬀerence in FENa2 and FENa4
between the two groups (Table 2). Mean creatinine clearance
in posttransplant day 10 was signiﬁcantly less in Group II
compared with Group I (P<. 05) (Table 2). There was no
signiﬁcant diﬀerence in BUN or sCr measured daily for ten
daysafterkidneytransplantation among twogroups(Figures
2 and 3).
Mean BUN and sCr on posttransplant day 10 was less in
G r o u pIc o m p a r e dw i t hG r o u pI I ,b u ti tw a sn o ts i g n i ﬁ c a n t
statistically (Table 2).
Mean duration of hospital stay from the ﬁrst posttrans-
plant day till normalization of renal function was about
5 . 2 d a y sl o w e ri nG r o u pIc o m p a r e dt oG r o u pI I ,a n dt h i s
diﬀerence was statistically signiﬁcant (P<. 05) (Table 2).
There was not any statistically signiﬁcant diﬀerence
between the rates of postoperative complications among the
two groups (Table 2).
Table 1: Preoperative characteristic of the donors and recipients.
Variable Group I Group II
(n = 25) (n = 28)
Donor
Age (years) 27.0 ± 4.8 32.0 ± 5.4
Sex (M/F) 25/0 28/0
Recipient
Age (yr) 39.6 ± 11.7 39.0 ± 13.1
Sex (M/F) 20/5 19/9
Anuria/oliguria 2/23 3/25
Duration of CRF (month) 40.0 ± 8 32.0 ± 9
DOH (month) 22.0 ± 4 23.0 ± 6
Cause of CRF
Glomerulonephritis 2 4
Hypertension 8 6
Diabetes mellitus 5 2
Pyelonephritis 1 1
SLE 1 2
ATN 1 0
Urologic disease 0 2
(VUR, nephrolithiasis,etc.)
Unknown 0 1
Other 7 10
Dates are presented as mean ± SD or numbers. Group I: living kidney
donor patients under open nephrectomy received high ﬂow oxygen; Group
II: living kidney donor patients under open nephrectomy received air. CRF:
chronic renal failure; DOH: duration of hemodialysis; SLE: systemic lupus
erythematosus; ATN: acute tubular necrosis; VUR: vesicoureteral reﬂux.
There was no signiﬁcant diﬀerence between the two groups.
4.Discussion
The major ﬁnding of our study was that the intermittent
exposure of living human kidney donors to the hyperoxia
improves early renal function measured in the ﬁrst ten days
after kidney transplantation.
Mean serum BUN and creatinine throughout posttrans-
plant day 1 to 10, creatinine clearance in day10, need to
additional diuretics in the ﬁrst 24hours after operation,
urine output during 6hours after operation, and also
duration of hospital stay were signiﬁcantly better in Group
I who were pretreated with hyperoxia compared with Group
II who had no such exposure.
As our study showed that the incidence of DGF was
insigniﬁcantly more in Group II (14.3%) compared with
Group I (4%). Generally, the great majority of kidney
transplants are carried out using kidneys from standard
criteria donorswith moderateDGFratesof21–31%[23, 24].
A number of factors have been documented to impact
short-term graft survival. These consist of delayed allograft
function, HLA antibodies, type of donor kidney, donor
illness, medical center factors, and other factors.
Allograft injury participates an important role in both
short- and long-term graft function, as well as in the
induction of renal allograft rejection [25]. Such injury
possibly is induced by diﬀerent events, including brain4 Journal of Transplantation
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Figure 1: Flow diagram of the progress through the phases of the randomised trial. Group I: living kidney donor patients under open
nephrectomy received high-ﬂow oxygen; Group II: living kidney donor patients under open nephrectomy received air.
death, cold ischemia time, ischemia and/or reperfusion, and
infection.
Ischemia and/or reperfusion injury is supposed to be a
critical risk factor for both early delayed graft function and
late allograft dysfunction.
The majorcauseofdelayedgraft functionispostischemic
acute tubular necrosis (ATN) [26]. A number of authors are
of the belief that duration of the vascular anastomosis more
than 35minutes may be a factor to the development of ATN
[27].
InSzostekand colleagues[28]study ,thevalueofeﬀective
cooling of the kidney during the vascular anastomosis
in preventing development of ATN was documented. In
univariate analysis of several factors that could be a factor
to the development of ATN, it was shown that donor
hypotension, type of kidney storage, and temperature rise
during the anastomosis had signiﬁcant eﬀect [28].
The conditions surrounding organ removal, storage, and
engraftment possibly will enhance graft immunogenicity
[29–31]. Such factors comprise the upregulation of major
histocompatibility complex (MHC) antigens and triggering
of the cytokine-adhesion molecule cascade [32, 33].
Old and very young kidneys have moderately reduced
numbers of functioning nephrons and stay alive less well
once transplanted. Besides fewer nephrons other factors
intrinsic to an older kidney may well impact whole allograftJournal of Transplantation 5
Table 2: Postoperative characteristic and complications of recipi-
ents.
Variable Group I
(n = 25)
Group II
(n = 28)
P value
NTAD
At ﬁrst hours AO 0α 4 .07
At 24hours AO 2∗ 10 .017
Urine output (mL)
At ﬁrst hours AO 516 ±443 451 ±428 .594
At 6hours AO 4522 ±1899∗ 3185 ±2253 .024
At 24hours AO 17990 ±6122 16368±20386 .704
NTH during ﬁrst week 1 4 .213
FENa2 (%) 7.2 ±4.57 .2 ±9.7 .979
FENa4 (%) 3.6 ±2.03 .3 ±4.3 .715
CrCL10 (mL/min) 61.6 ±18.6∗ 49.8 ±20.0 .033
Creatinine10 (mg/dL) 1.8 ±0.71 .96 ±0.9 .522
BUN10 (mg/dL) 34 ±12 38.2 ±19.7 .352
Hospital stays (days) 13.9 ±2.7∗ 19.1 ±10.1 .025
Complications 4 6 .450
Acute rejection 4 4
ATN 0 1
MI 0 1
Date are presented as mean ± SD or numbers. Group I: living kidney donor
patients under open nephrectomy received high-ﬂow oxygen; Group II:
living kidney donor patients under open nephrectomy received air. NTAD:
needtoadditionaldiuretic;AO:afteroperation;NTH:needtohemodialysis,
FENa2: fractional excretion of sodium at posttransplant day 2; CrCL10:
creatinine clearance throughout posttransplant day 1 to 10; BUN10: blood
urea nitrogen throughout posttransplant day 1 to 10; ATN: acute tubular
necrosis; MI: myocardial infarction. ∗P< . 05 versus Group II. αP = .07.
survival [34]. Large sized recipients put a great physiologic
demand on moderately “inadequate” numbers of trans-
planted nephrons possibly will be a factor in the lower graft
survival rate [35].
Diﬀerences in the capacity to produce an eﬃcient
immune response versus the allograft as well as variations
in primary factors inﬂuencing allograft ﬁbrosis signify
alloantigen-independent factors that may impinge on graft
survival [36].
The above-discussed factors are the main cause of graft
survival that may inﬂuence 14.3% incidence of DGF in the
Group II patients. One limitation of our study was that we
did not investigate the role of each factor separately.
The methods used in our study did not allow us to
identify the mechanisms by which hyperoxic precondition-
ing protected the transplanted kidney. We hypothesized that
increased oxygen volume dissolved in blood plasma resulted
in enhanced oxygen supply to marginally perfused tissue.
Higher plasma oxygen concentration possibly will be
important because capillary blood ﬂow during ischemia can
mainly consist of plasma ﬂow [37]. Better oxygen delivery
may have led to improvement of energy metabolism in
penumbral regions and decreasing their vulnerability to
additional metabolic challenges such as peri-infarct depolar-
izations [38].
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Figure 2: Comparison of blood urea nitrogen (BUN) measured
daily for ten days after kidney transplantation in two groups. Dates
are presented as mean ± SD. Group I: living kidney donor patients
under open nephrectomy received high-ﬂow oxygen; Group II:
living kidney donor patients under open nephrectomy received air.
B: blood urea nitrogen. BUN was less in Group I compared with
Group II on postoperative days of 3–10, but it was not statistically
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Figure 3: Comparison of serum creatinine measured daily for ten
daysafterkidneytransplantationintwogroups.Dates arepresented
as mean ± SD. Group I: living kidney donor patients under open
nephrectomy received high-ﬂow oxygen; Group II: living kidney
donor patients under open nephrectomy received air. C: serum
creatinine. There was no signiﬁcant diﬀerence between the two
groups.
On the other hand, several other mechanisms implicated
in ischemia and reperfusion injury may be inﬂuenced by
hyperoxia. Ahrens and colleagues [39]f o u n dad e c r e a s eo f
infarct sizeinmicewhich hadbeenpretreatedwithhyperoxia
several days before focal ischemia. This preconditioning
eﬀect might suggest that hyperoxia triggers reactive de novo
expression of protective genes taking part in free radicals
decay.
Thom et al. [40] and Warner et al. [41] showed that
hyperoxia treatment inhibited the function of neutrophil
beta-2-integrin, a molecule involved in leukocyte adhesion
and reperfusion injury.
For the following reasons, oxygen-free radicals (OFRs)
may present a common signal in ischemic tolerance (IT)
induction: (1) the majority if not all of published tolerance6 Journal of Transplantation
inducing stimuli are associated with the production of OFR;
(2) induction of antioxidant enzymes has been shown for
many IT protocols; (3) OFR itself may induce IT [42].
Hyperoxic oxygenation, the exposure of an organism
to an environment of relatively pure oxygen, increases
physiological OFR production in all organs, including the
kidney [43–45].
Rasoulian et al. [21] and Wahhabaghai et al. [22]s h o w e d
thatintermittentpre-exposuretohyperoxicenvironmentcan
reduce subsequent renal ischemic injury in rats.
The mechanism of advantage of hyperoxemia might
involve the vascular element with impaired autoregulation
in the area of ischemia. Vasoconstriction caused by a high
PaO2 permits shunting of blood into the infarct from nearby
normal brain [46].
Donor hyperoxia, deﬁned as a PaO2 value more than
150mmHg,wasassociated with improvedgraft survivaleven
independently from the classiﬁcation of the quality of early
postoperative graft function. Donor hyperoxia might induce
good early postoperative liver function by improving ATP
hepatic content, increasing protein synthesis, and decreasing
the proteolytic process in the liver. It was also proposed
that donor hyperoxia could be valuable, as it has been
demonstrated experimentally that hyperoxic pretreatment
attenuates ischemic-reperfusion injury of the heart [18, 47],
brain [19, 48], spinal cord [20], liver [49], and kidney [21,
22].
We hypothesize that early hyperoxia treatment may
prolong the short-time window for therapeutic interven-
tions, a major management problem in ischemic stroke.
Nevertheless, we caution against overinterpretation of our
data because we did not study the eﬀect of hyperoxia
during reperfusion or in permanent focal ischemia. Future
studies should address these issues and recognize the exact
mechanisms and pathophysiologic targets of hyperoxia.
Pure oxygen at atmospheric pressure is nontoxic if given
for less than 6hours, and 80% oxygen could be administered
for 24hours [50] far away from four times of one-hour
exposure which was employed in our study.
The most important complication of short periods of
oxygen administration is pulmonary atelectasis [51]a n d
vomiting[51].Preoxygenationwith80%oxygenisassociated
with signiﬁcantly lower rates of atelectasis compared with
100% oxygen [52]. Not only pure oxygen but also 80%
oxygen has protective eﬀectson rat heart tissue [18],and this
may be correct for other tissues like kidney and keeps on to
be studied.
In conclusion, intermittent exposure of human living
kidney donors to hyperoxic environment improves renal
function in early period following kidney transplantation.
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